BR112018001292A2 - métodos para melhor liberação de agentes ativos a tumores - Google Patents

métodos para melhor liberação de agentes ativos a tumores

Info

Publication number
BR112018001292A2
BR112018001292A2 BR112018001292A BR112018001292A BR112018001292A2 BR 112018001292 A2 BR112018001292 A2 BR 112018001292A2 BR 112018001292 A BR112018001292 A BR 112018001292A BR 112018001292 A BR112018001292 A BR 112018001292A BR 112018001292 A2 BR112018001292 A2 BR 112018001292A2
Authority
BR
Brazil
Prior art keywords
methods
tumors
active agents
better release
agents
Prior art date
Application number
BR112018001292A
Other languages
English (en)
Inventor
Frederick Ross Russell
Original Assignee
Kimberly Clark Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kimberly Clark Co filed Critical Kimberly Clark Co
Publication of BR112018001292A2 publication Critical patent/BR112018001292A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0038—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061—Methods for using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

a presente invenção diz respeito à entrega de agentes através da pele. os métodos para fornecer agentes, tais como agentes bioativos, são contemplados pela presente invenção. especificamente, métodos para a entrega direcionada de agentes para uma ou mais áreas da epiderme e, assim, para um ou mais tumores de câncer são descritos.
BR112018001292A 2015-07-24 2016-07-22 métodos para melhor liberação de agentes ativos a tumores BR112018001292A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562196570P 2015-07-24 2015-07-24
US201562196578P 2015-07-24 2015-07-24
PCT/US2016/043623 WO2017019526A2 (en) 2015-07-24 2016-07-22 Methods for better delivery of active agents to tumors

Publications (1)

Publication Number Publication Date
BR112018001292A2 true BR112018001292A2 (pt) 2018-09-11

Family

ID=57885141

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018001292A BR112018001292A2 (pt) 2015-07-24 2016-07-22 métodos para melhor liberação de agentes ativos a tumores

Country Status (15)

Country Link
US (3) US10806913B2 (pt)
EP (2) EP3925599A1 (pt)
JP (1) JP7082041B2 (pt)
KR (1) KR20180035209A (pt)
CN (1) CN107921248A (pt)
AU (3) AU2016297823B2 (pt)
BR (1) BR112018001292A2 (pt)
CA (1) CA2991455C (pt)
DK (1) DK3325080T3 (pt)
ES (1) ES2891523T3 (pt)
HU (1) HUE056410T2 (pt)
MX (2) MX2018000166A (pt)
PL (1) PL3325080T3 (pt)
RU (1) RU2719943C2 (pt)
WO (1) WO2017019526A2 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107921248A (zh) * 2015-07-24 2018-04-17 金伯利-克拉克环球有限公司 用于向肿瘤更佳地递送活性剂的方法
KR20180035210A (ko) * 2015-07-24 2018-04-05 킴벌리-클라크 월드와이드, 인크. 활성제의 류마티즘 전달 방법
US11541015B2 (en) 2017-05-17 2023-01-03 Massachusetts Institute Of Technology Self-righting systems, methods, and related components
EP3624887A4 (en) 2017-05-17 2021-02-24 Massachusetts Institute of Technology TISSUE ANCHORING ARTICLES
EP3652133A4 (en) 2017-07-10 2021-04-21 Basf Se MIXTURES INCLUDING A UREASE INHIBITOR (IU) AND A NITRIFICATION INHIBITOR SUCH AS 2- (3,4-DIMETHYL-1H-PYRAZOL-1-YL) SUCCINIC ACID (DMPSA) OR 3,4-DIMETHYL PYRAZOLIUM GLYCOLATE (DMPG)
WO2019222570A1 (en) 2018-05-17 2019-11-21 Massachusetts Institute Of Technology Systems for electrical stimulation
AU2019277577A1 (en) * 2018-05-31 2020-12-24 Vivasor, Inc. Drug delivery methods targeting the lymphatic system
US20210308440A1 (en) * 2018-09-24 2021-10-07 L'oreal Device comprising microneedles for skin-coloring
US20230001170A1 (en) 2019-12-05 2023-01-05 Sorrento Therapeutics, Inc. Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic devliery device
EP4281167A1 (en) 2021-01-22 2023-11-29 Sorrento Therapeutics, Inc. Device for microliter-scale lymphatic delivery of coronavirus vaccines
WO2022192594A2 (en) 2021-03-11 2022-09-15 Sorrento Therapeutics, Inc. Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease
AU2022290563A1 (en) 2021-06-09 2024-01-25 Vivasor, Inc. Method of treating cancer by administration of an anti-pd-1 or anti-pd-l1 therapeutic agent via a lymphatic microneedle delivery device
WO2023023074A1 (en) 2021-08-18 2023-02-23 Sorrento Therapeutics, Inc. Therapeutic agents targeting the lymphatic system

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE72524B1 (en) 1994-11-04 1997-04-23 Elan Med Tech Analyte-controlled liquid delivery device and analyte monitor
AU785199B2 (en) 2000-06-01 2006-11-02 Watson Pharmaceuticals, Inc. Transdermal delivery of lasofoxifene
JP4383168B2 (ja) * 2001-09-12 2009-12-16 ベクトン・ディキンソン・アンド・カンパニー マイクロ針投与デバイスおよび薬物投与デバイス
JP2007500251A (ja) * 2003-06-13 2007-01-11 ベクトン・ディキンソン・アンド・カンパニー 生物学的に活性な作用物質の改良型皮内送達
WO2005023328A2 (en) 2003-08-26 2005-03-17 Becton Dickinson And Company Methods for intradermal delivery of therapeutics agents
AU2005284908B2 (en) 2004-09-13 2011-12-08 Morningside Venture Investments Limited Biosynchronous transdermal drug delivery
US20070088414A1 (en) * 2005-05-25 2007-04-19 Campbell Robert L Particulate formulations for intradermal delivery of biologically active agents
WO2006138719A2 (en) * 2005-06-17 2006-12-28 Georgia Tech Research Corporation Coated microstructures and method of manufacture thereof
US8197435B2 (en) 2006-05-02 2012-06-12 Emory University Methods and devices for drug delivery to ocular tissue using microneedle
EP2100850A1 (en) * 2008-03-11 2009-09-16 Stichting Voor De Technische Wetenschappen Microneedle array and a method for manufacturing microneedles
US8715736B2 (en) 2009-04-30 2014-05-06 Florida Agricultural And Mechanical University Nanoparticle formulations for skin delivery
CN101829394B (zh) * 2010-04-27 2012-08-22 上海交通大学 台阶微针阵列的制备方法
CA2797202A1 (en) 2010-04-28 2012-02-16 Kimberly-Clark Worldwide, Inc. Injection molded microneedle array and method for forming the microneedle array
JP5860033B2 (ja) 2010-04-28 2016-02-16 キンバリー クラーク ワールドワイド インコーポレイテッド ｓｉＲＮＡ送達用の医療デバイス
US9586044B2 (en) 2010-04-28 2017-03-07 Kimberly-Clark Worldwide, Inc. Method for increasing the permeability of an epithelial barrier
JP5860032B2 (ja) 2010-04-28 2016-02-16 キンバリー クラーク ワールドワイド インコーポレイテッド 関節リウマチ薬の送達のためのデバイス
US20120187814A1 (en) 2011-01-25 2012-07-26 Fryling Nicholas A Furniture System and a Frame Assembly for a Furniture System
US20120245445A1 (en) * 2011-03-21 2012-09-27 Michael Darryl Black Glucose Monitoring System
AU2012326203B2 (en) 2011-10-17 2017-11-30 Massachusetts Institute Of Technology Intracellular delivery
KR102388880B1 (ko) * 2011-10-27 2022-04-22 소렌토 쎄라퓨틱스, 인코포레이티드 고점도 생체활성 제제의 경피 전달 방법
KR101575039B1 (ko) * 2012-07-19 2015-12-07 (주)아모레퍼시픽 노즐 장치 및 이를 포함하는 최소 침습형 주입 장치
CN110025881A (zh) * 2012-09-13 2019-07-19 亚夫拉罕·阿米尔 用于皮肤改善的递送装置和方法
AU2013318338B2 (en) 2012-09-21 2017-05-25 Intensity Therapeutics, Inc Method of treating cancer
CN103157178B (zh) * 2013-02-05 2014-12-31 北京化工大学 精确控制微针插入长度的印章式工具
US9861801B2 (en) 2013-02-28 2018-01-09 Kimberly-Clark Worldwide, Inc. Drug delivery device
US10183156B2 (en) 2013-02-28 2019-01-22 Sorrento Therapeutics, Inc. Transdermal drug delivery device
BR112015027608A2 (pt) 2013-05-23 2017-07-25 Kimberly Clark Co microagulhas com geometrias transversais de canal aberto melhoradas
US10376674B2 (en) * 2014-09-15 2019-08-13 Ethicon, Inc. System and method for targeted delivery of therapeutic agents to tissue
KR20180035210A (ko) * 2015-07-24 2018-04-05 킴벌리-클라크 월드와이드, 인크. 활성제의 류마티즘 전달 방법
CN107921248A (zh) * 2015-07-24 2018-04-17 金伯利-克拉克环球有限公司 用于向肿瘤更佳地递送活性剂的方法

Also Published As

Publication number Publication date
AU2016297823B2 (en) 2020-10-22
RU2719943C2 (ru) 2020-04-23
MX2022014277A (es) 2022-12-07
US20180193624A1 (en) 2018-07-12
US20240238570A1 (en) 2024-07-18
JP7082041B2 (ja) 2022-06-07
EP3325080A2 (en) 2018-05-30
WO2017019526A2 (en) 2017-02-02
EP3325080B1 (en) 2021-09-01
AU2022275397A1 (en) 2023-01-05
RU2018104102A3 (pt) 2019-11-06
CN107921248A (zh) 2018-04-17
EP3925599A1 (en) 2021-12-22
JP2018521755A (ja) 2018-08-09
US10806913B2 (en) 2020-10-20
CA2991455C (en) 2023-10-10
ES2891523T3 (es) 2022-01-28
AU2021200146A1 (en) 2021-03-18
EP3325080A4 (en) 2019-04-17
AU2021200146B2 (en) 2022-08-25
KR20180035209A (ko) 2018-04-05
AU2016297823A1 (en) 2018-02-15
CA2991455A1 (en) 2017-02-02
US20210052871A1 (en) 2021-02-25
PL3325080T3 (pl) 2022-01-24
RU2018104102A (ru) 2019-08-27
DK3325080T3 (da) 2021-10-04
HUE056410T2 (hu) 2022-02-28
MX2018000166A (es) 2018-03-26

Similar Documents

Publication Publication Date Title
BR112018001292A2 (pt) métodos para melhor liberação de agentes ativos a tumores
CL2018001152A1 (es) Composiciones y métodos para el tratamiento del cáncer
CL2018001685A1 (es) Compuestos heterociclicos como inmuno moduladores.
CY1124595T1 (el) Ρυθμιση δραστικοτητας συμπληρωματος
CL2019002304A1 (es) Compuestos para el tratamiento del cáncer.
BR112017024384A2 (pt) bactérias modificadas para reduzir hiperfenilalaninemia
CO2017011183A2 (es) Inhibidores de indolamina-2,3-dioxigenasa composiciones que los contienen y métodos de preparación
CL2019002461A1 (es) Arn terapéutico.
ECSP17073743A (es) Moduladores de k-ras
CL2017001459A1 (es) Biarilo compuestos útiles para el tratamiento de enfermedades humanas en oncología, neurología e inmunología
BR112018001435A2 (pt) métodos para entrega linfática de agentes ativos
CL2017001204A1 (es) Derivados de 6-amino-7-biciclo-7-deaza-purina como inhibidores de la proteína quinasa
CL2018002814A1 (es) Composiciones y metodos para el tratamiento de heridas, trastornos, y enfermedades de la piel.
CL2018003265A1 (es) Modulares del receptor espiro-lactama n-metil-d-aspartato y usos de los mismos.
PE20180243A1 (es) Composiciones que comprenden cepas bacterianas
CL2018003123A1 (es) Terapia de combinación para el tratamiento del cáncer
CR20150316A (es) Compuestos y sus métodos de empleo
BR112018003269A2 (pt) conjugados de fármaco-anticorpo anti-dll3 e métodos de utilização
CY1124761T1 (el) Ρυθμιστες της δραστικοτητας του συμπληρωματος
CO2017007121A2 (es) Compuestos bicíclicos fusionados para el tratamiento de enfermedades
BR112016012713A2 (pt) Método para tratamento de câncer em um paciente necessitado, e, método de selecionar um paciente para um método de tratamento
MA34057B1 (fr) Compositions et methodes pour le diagnostic et le traitement d'une tumeur
TR201901077T4 (tr) Kanser Veya Enfeksiyon Tedavisine Yönelik Birleşik Preparasyonlar
CY1122968T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει μια ενωση διαμινο-ετεροκυκλικου καρβοξαμιδιου ως δραστικο συστατικο
CL2015003343A1 (es) Composición farmacéutica que comprende un agente terapéutico modificado en base a hemoglobina, para el tratamiento para tratar el cáncer, e imágenes de diagnóstico.

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: SORRENTO THERAPEUTICS, INC. (US)

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements